Comments submitted to the Microgravity Review Panel

Interested parties were invited through the web site to submit comments to the Microrogravity Review Panel during October and November 2002.

There were 45 responses, all of which were presented to the Panel for consideration.

Each respondent was asked if their submission could be published, and 39 replied that they were content (no reply was taken to mean consent was withheld). These responses are given below:

Prof J E Allen, Oxford University
Prof O Alpar, School of Pharmacy, University of London
Dr LG Briarty, ex University of Nottingham
Dr Rob Buckle, Medical Research Council
Dr Anthony MJ Bull, Imperial College London
Prof Naomi Chayen, Imperial College London
Prof WT Coakley, Cardiff University
Dr Charles Cockell, British Antarctic Survey
Prof JL Culhane, FRS, University College London/Mullard Space Science Laboratory
Dr Nick Davey, Imperial College London
Prof Howell G.M Edwards, Bradford University
Dr Kevin Fong BSc MBBS MRCP, University College London
Dr Peter J. Fraser, Aberdeen University
Prof Allen Goodship, Royal Veterinary College and University College London
Dr Monica M. Grady, Natural History Museum
Dr Mike Grocott MBBS MRCP FRCA, University College London
Prof LD Hall, University of Cambridge
Dr M H Harrison, QinetiQ Ltd
Prof. JD Hunt FRS, University of Oxford
Dr DBR Kenning, University of Oxford
Dr Peter D. Lee, Imperial College London
Dr Denny Levett MA BM BCh MRCP, University College London
Dr Nicholas Lockerbie, University of Strathclyde
Roger Longstaff, Guest Associates (Europe) Ltd.
Prof. Matthew J. Dring & Dr. Thomas Wiedemann, Queen's University Belfast
Dr Patrick Magee, University of Bath
Dr M. A. Mendes-Tatsis, Imperial College London
Dr Hugh Montgomery, University College London
Prof Marco Narici, Manchester Metropolitan University
Prof Terence Partridge, Medical Research Council
Dr Peter Quested, NPL & Prof Ken Mills, Imperial College London
Dr Jonathan Reeve, Addenbrooke's Hospital
Professor Michael J Rennie PhD FRSE, University of Dundee (now Nottingham)
Dr TJ Stevenson, University of Leicester
Dr J R R Stott, QinetiQ Ltd
Prof Ian A. Sutherland, Brunel Institute for Bioengineering
Prof Pankaj Vadgama, Queen Mary, University of London
Dr T L Whateley, University of Strathclyde

Name

Professor J.E.Allen

Affiliation

University of Oxford

Address

Department of Engineering Science

University of Oxford

Parks Road

Oxford OX1 3PJ

Telephone

01865 273000

Fax

01865 273010

E-mail

john.allen.eng.ox.ac.uk

Brief summary of main points

   I wish to make a firm proposal that the United Kingdom should take part in the programme of research using the International Microgravity Plasma Facility (IMPF) to be installed on the International Space Station. The IMPF project began as a proposal to the European Space Agency (ESA) in 1999. This proposal was one of six to receive the highest rating in ESA's international peer review. As a result an International Advisory Board was formed whose duties, in the first place, were to make recommendations to the German Aerospace Centre (DLR). A feasibility study was then carried out by the German Company Kayser-Threde, funded by the DLR. Subsequently an International Announcement of Opportunity for Microgravity Research was made.

   I have been a member of the Advisory Board for the International Microgravity Plasma Facility (IMPF) since its inception. All the recommendations of this board are readily available on the web at <http:/www.microgravity.net>. I am also a member of an active European Network on Complex (Dusty) Plasmas; seven laboratories are engaged in this activity, in Germany, Norway, Italy, Portugal and the UK.

Further details and background

.Scientific and Technological Relevance

   The basic science in this project is that of the study of the behaviour of dust particles in a plasma. Such particles are somewhat like floating Langmuir probes in that no net current flows to them. In the steady state case the electron current and the ion current must therefore be equal, if secondary emission is negligible. The dust particle then acquires a negative charge, of the order of 10,000 electrons and a corresponding negative potential. The particles then interact with each other and can form "crystal-like" structures, or behave more like liquids or gases. The mixture of dust particles, ions and electrons is sometimes referred to as a "colloidal plasma". However the analogy cannot be carried too far, because the system is not in thermal equilibrium.

   The interaction between particles is not completely understood. Clearly there is a repulsive force, since they are all negatively charged (in the vast majority of cases).

Some experimental reports in the literature describe a screened Coulomb potential, but agreement has not yet been reached on the factors that determine the screening length. One of the difficulties here is that laboratory experiments have been carried out on the behaviour of dust particles in a space charge sheath. This is because the weight of the dust pulls the dust particles out from the plasma and into the adjacent sheath. These experiments are of considerable interest but experiments in the central plasma region are essential, which is the reason for devising experiments to be performed on the International Space Station, where gravitational effects are practically eliminated. The technological relevance relates largely, but not exclusively, to nanotechnology. As an example, microcrystals can be grown in plasma discharges in Silane or Methane and very interesting results have been obtained on the growth of microcrystalline silicon films at the Ecole Polytechnique in Paris. Techniques for manipulating particles are being developed, in a number of laboratories, which suggests the manufacture of some very interesting microelectronic devices. The first experiments on moving dust particles around in a plasma, using a low power laser beam, were in fact carried out in Oxford. Industrial aspects will be pursued by an IMPF team led by Professor G. Kroesen of the Eindhoven University of Technology in the Netherlands; their work includes particle growth, particle coating and the avoidance of the agglomeration of microcrystals. This is clearly long-term research, but is very likely to open up new areas of technology in ground-based industry.

   In general the research is of interest to three different communities: those working in space science, those working in technological plasmas and those working in basic plasma physics. In space science dust is important in interstellar clouds, comets, interplanetary dust, the magnetosphere, the ionosphere and planetary rings. Needless to say, plasma is ubiquitous, so the dust particles will become charged. Much of this dust is in regions where gravity is unimportant. The technological relevance has already been referred to. One can add that nowadays particles are grown in gas discharge plasmas for use as chemical catalysts and for compression into new materials with improved mechanical properties; such research has been carried out for some years at the Ecole Polytechnique de Lausanne, Switzerland. Turning to basic plasma physics, once dust is introduced into a plasma the whole subject needs to be re-examined ab initio. It must be remembered that we are not simply introducing additional heavy and highly charged ions into the system. The dust particles act as sinks for charged particles; one can add that the existing theoretical literature is largely unsatisfactory in this respect. One aspect of experiments with dust particles is that it they can be used for diagnostic purposes to determine electric field distributions in plasmas and sheaths.

 

 

 

 

Name

Prof. H. Oya Alpar

Affiliation

School of Pharmacy, University of London

Address

Centre for Drug Delivery Research

29 – 39 Brunswick Square

London WC1N 1AX

Telephone

020 7753 5928

Fax

020 7753 5942

E-mail

Oya.alpar@ams1.ulsop.ac.uk

Brief summary of main points

As a member of the ESA Topical Team, I would like to impress the importance of an active UK involvement in the ESA ELIPS (European Programme for Life and Physical Sciences) and the use of the International Space Station. Our project aims fall within that of improving health, and innovating technologies and processes, and I feel access to ISS and ESA support is essential to achieve our objectives. Together with this we should also form strong links with NASA to achieve synergy in intellectual advancement and health benefit.

Further details and background

Microsphere and microencapsulation technologies have found application in a range of industries, from pharmaceutical and biomedical to agrochemical and electronics. There are however, fundamental processes involved in the microencapsulation process for which a more detailed and mechanistic understanding is required. For example the interfacial phenomena occurring during solvent exchange at the solid/liquid and liquid/liquid interfaces, and the increased crystallinity of large polymer molecules. The microgravity environment of the ISS provides the ideal environment to isolate the different aspect of the microencapsulation process for a more comprehensive approach to the work.

 

Using a requisite multidisciplinary approach, elucidation of these mechanisms will provide a strong platform for further development of microsphere delivery systems for gene, vaccine and drug delivery, as well as biomedical diagnostic technologies.

 

In addition to the contribution to the advancement of science, and its implication on terrestrial health, there is also considerable commercial benefit to be gained by improving on microencapsulation technology.

 

 

Name

Dr LG Briarty

Affiliation

University of Nottingham (retired18 months ago)

 

Address

9 The Cloisters

Beeston

Nottingham

NG9 2FR

UK

Telephone

(44) (0) 115 9250 964

Fax

 

E-mail

lgbriarty@waitrose.com

Brief summary of main points

 

The UK does have a number of groups capable of and interested in

microgravity research, but the current research organisation and funding

climate mitigates against their taking up this interest.

 

Goodwill towards the UK from ESA in microgravity research has been

significant in the past as I can testify from my own experience as a PI on

various missions (Shuttle IML-1, two parabolic flights, Foton 12 mission).

This can't last much longer unless  we make some real investment in the

programme; the result of the UK's "wait and see approach" must  be a cooling

off and even antagonism towards UK useage of the ISS.

 

Throughout Europe the first generation of space-experienced researchers is

nearing retirement.  In most other countries a further generation is being

brought on and it is these who will understand and make use of the ISS as a

research facility.  This isn't the case in the UK and again we risk being

left out.

 

As well as being a research facility the ISS is a major stimulus to

international scientific collaboration.  It will result in new and expanded

research programmes from which the UK risks being left out.

 

Hope this helps

 

Greg Briarty

 

 

 

 

 

 

Further details and background

 

 

 

 

 

 

Name

Dr Rob Buckle

Affiliation

Medical Research Council

Address

20 Park Crescent

London W1B 1AL

Telephone

020 7636 5422

Fax

020 7670 5124

E-mail

robin.buckle@headoffice.mrc.ac.uk

Brief summary of main points

MRC has recently been examining its research strategy in relation to space-based biomedical research programmes, and to this end the MRC and BNSC recently hosted an international workshop to discuss this issue, and the benefits that such programmes might provide for terrestrial health needs.

The preliminary conclusion reached is that a strong case has not been made for making significant investments in this area, and MRC could not support the earmarking of funds for such research programmes unless this was additional to the current research budget.

More specifically:

·         While biomedical research in space is clearly needed to support the programmes of manned space flight, the main benefit of such research is to the health of astronauts, rather than to the health of the terrestrial population.

·         The UK has several pockets of excellent research in this area, although there is currently a lack of critical mass and co-ordination, and links to the broader biomedical community are weak. Nevertheless, some possibilities exist for improved interaction with those co-ordinating NASA and ESA-funded programmes.

·         Any decision to commit funding towards space research programmes should only be taken once a rigorous cost / benefit analysis has been undertaken.

 

Further details and background

 

The MRC and BNSC recently hosted a one-day workshop entitled ‘Space for health, or health for space?’ at the Royal Society in London on 5 August 2002. This workshop followed an earlier consultation exercise undertaken in 2001, during which the MRC asked both national and international scientists involved in microgravity research to advise on the scientific opportunities afforded by microgravity for research in cell biology and physiology. The workshop brought together 30 leading scientists from both the UK and overseas to discuss the opportunities presented by space-based research programmes in the area of biomedicine, and the benefits that such programmes might provide for terrestrial health needs. The meeting was structured to allow discussion of the role of space research in four areas of physiology – bone, muscle, cardiovascular and neuro-physiology.

 

The main aims of the workshop were:

·         To inform MRC’s research strategy in relation to biomedicine and space, given that research funded by MRC must ultimately address the health needs of the UK population and UK wealth creation.

·         To identify if there are unique opportunities afforded by research in space that might prove beneficial to terrestrial health.

·         To inform MRC’s and the other Research Council’s position on the value of “microgravity” as a platform / tool for research, and on potential UK participation in the ESA Life and Physical Sciences Programme (ELIPS)

·         To help assess the competitiveness of the UK in space biomedicine.

·         To identify how research activities linked to space programmes might be most effectively linked to the non-space scientific community.

·         To identify the opportunities and benefits of engaging more closely with ESA and NASA over the medium/longer term.

 

An expert advisory group was also present throughout the workshop, were asked to draw some conclusions and recommendations based upon the presentations and discussions of the workshop. This group met privately towards the end of the workshop and came to the following conclusions:

 

·         Biomedical research in space is clearly needed to support the programmes of manned space flight. The main benefit of such research is to the health of astronauts, rather than to the health of the terrestrial population.

·         While the UK has several pockets of excellent research in this area, there is currently a lack of critical mass and co-ordination, while links to the broader biomedical community are weak.

·         Microgravity provides an interesting tool with which to probe normal human physiology, although its relevance to pathophysiology needs to be more convincing.

·         Investigations into the loss of bone and muscle mass in conditions of microgravity may further our understanding of the basic mechanisms underlying the turnover of such tissue. However it has yet to be established whether this is a useful model in terms of understanding the processes of ageing.

·         The studies being performed in space offer some unique possibilities for the area of human physiology. For example, whole organism experiments can be performed in the human context, and dissociation studies are also possible. However the majority of important questions being posed could be tackled on earth by careful design.

·         Cardiovascular physiology represents an area of opportunity to further understand basic physiological processes, although space studies do not provide a good model for heart failure and other cardiovascular disease processes.

·         The area of neurovestibular research offers some possibilities, for example in relation to sensory-motor integration studies and cellular/molecular adaptation, although UK efforts in space research in this area are modest. Furthermore there are increasing terrestrial opportunities offered by virtual reality approaches

·         Current studies are generally descriptive, and the knowledge base at present is insufficient to ask the critical questions that microgravity might be able to uniquely answer.

·         The study population in space research is atypical, since astronauts are a highly selected group of fit and intelligent individuals.

·         The small numbers of astronauts that can be analysed gives rise to problems of statistical power in space research, and effort should be put into establishing new biostatistical methodology.

·         Space programmes may have a role for the development of bioinstrumentation, such as miniaturised imaging modalities; however the lack of statistical power in space studies will remain to be a problem

·         Due to its greater investment in manned space flight, NASA has a more significant biomedical research programme, and a larger physiological database, than ESA.

·         Any decision to commit funding towards space research programmes should only be taken once a rigorous cost / benefit analysis has been undertaken

·         The UK should establish better links between its biomedical researcher community and those involved in space research (through NASA and ESA). Opportunities exist for improving the design of the experiments performed in space, and UK experts could make valuable contributions in this area.

 

 

Name

Anthony MJ Bull

Affiliation

Imperial College London

Address

Department of Bioengineering

Imperial College

London SW7 2BX

Telephone

+44 20 7594 5186

Fax

+44 870 125 4985

E-mail

a.bull@imperial.ac.uk

Brief summary of main points

 

To quickly summarise my relevant research interest, it is chiefly in the field of movement analysis and the mechanics of joints in microgravity. I have some experience of microgravity research, undertaking flights with both ESA and with the Russians.

 

I and my colleagues would wish to be able to maintain and obtain extended access to parabolic flight programmes in the future. This work simply cannot be attempted without these experimental conditions.

 

If you wish to know a little more about the work, then do contact me.

 

 

 

 

 

 

 

Further details and background

 

Joint loading in microgravity: muscle optimisation of movement. Different muscular control strategies for movement. Applications of the work: devising different control strategies of bone loading - redistributing load on the joint, bone re-modelling (osteoporosis applications).

 

 

 

 

 

 

 

 

 

 

Name

Naomi Chayen

Affiliation

Imperial College London

Address

Biological Structure and Function Section,

Division of Biomedical Sciences,

Faculty of Medicine, Imperial College of Science,

Technology and Medicine,

London SW7 2AZ, U.K.

Telephone

020-75943240

Fax

020-75943169

E-mail

n.chayen@ic.ac.uk

Brief summary of main points

 

Why crystallise proteins?

 

Protein crystallisation has gained a strategic and commercial relevance in the post-Genomic era in which X-ray crystallography will play a major role. Current genome projects are expected to reveal numerous new targets for therapy of human disease.  However, it is usually not the genes themselves which are the targets, but the proteins encoded by them. The function of these proteins is determined by their three-dimensional structure and drugs can influence the function by precise atomic interactions with the protein. The most powerful technique for determining protein structure is X-ray crystallography, which is totally dependent on highly ordered crystals. Obtaining such crystals is the major bottleneck to structure determination. With the advent of Structural Genomics this problem is becoming increasingly acute giving rise to an urgent need for designing new and improved methods for producing high quality crystals. The demand for structures is not only in the medical sector but also in industries that utilise protein engineering for making a variety of  products (agricultural, washing powders, sugars and many other products).  It is often the case that crystals are produced, but they are not of good enough quality to undergo X-ray analysis. It is still not understood why some proteins (as well as other biological macromolecules) do crystallise with ease, while most refuse to produce suitable crystals. Better understanding of the fundamental principles of the crystallisation process will enable the design of new and improved methods for producing the desired crystals.

 

Current problems regarding crystallization in Space

 

The issue of crystallisation in Space is a controversial one due to conflicting results reported in the scientific literature.  A large number of scientific publications report that crystallisation of macromolecules in microgravity does indeed improve the quality of the crystals obtained. On the other hand, there are other reports opposing this claim, this is mailnly due to the fact that the success rate of protein crystallisation in Space has to date, only been 20%.  The reasons for this are only now beginning to emerge.  In recent years, experiments in micogravity are being conducted in a far more systematic way compared to previous experiments which were heavily reliant on luck. This is due to improved apparatus and awareness of the subject. With the aid of CCD video and other diagnostic tools it is now possible to monitor crystal growth in Space. As a result, researchers are beginning to realise the crucial factors on which to focus when conducting experiments in Space. (e.g. the importance of finding the optimal conditions in Space which may be totally different from the optimal conditions on Earth as well as the consequence of choosing the right method of crystallization).  A variety of apparatus made by NASA and The European Space Agency (ESA) for conducting both screening and diagnostic experiments in microgravity is now available using all methods of crystallization.

 

British Experiments

British scientists have set some bench marks and have influenced the way of conducting protein experiments in microG which others are following (e.g. highlighting of the work done by  Helliwell in Science (1995) 270, 1921; discontinuation of the vapour diffusion method by ESA based on the results of Chayen and Helliwell (1999) Nature 398, 20). Dr Skinner who was in Cambridge (but left for the USA) did an experiment in 1994 with a team of Europeans and Americans that showed improvement in diffraction of microG grown crystals. This experiment was not via ESA but using NASA apparatus. I have acted as Principal investigator on ESA, NASA and Russian missions, some in collaboration with other British scientists. Each of these misssions resulted in publications (listed in the next page) showing that microgravity has an effect, in most cases beneficial. Our experiments (all via ESA) have lead to new understanding of the process of crystal growth in microgravity which offer an explanation as to why in some cases the benefits were not full (Collaboration between Royal Holloway, Manchester and Imperial). I am currently designing new reactors for protein crystallisation is Space together with a German company working for ESA.

 

During the period of flying via ESA, We UK Scientists did the microG work without any support, really in our spare time, while the other Europeans received handsom funding form their National Agencies. But, at least we had the flight opportunities which are now at threat. Because the UK has been taken off the ESA missions, I am currently flying protein crystallisation experiments directly via NASA at their invitation, but one cannot be sure how long such a 'private' arrangement would last. I aim to fly the Lobster protein which has recently had wide media coverage.

 

Protein crystallisation in MicroG lost credibility in its early days due to over stating of its merits by some American Scientists. In recent years the experiments are being done more thoroughly and critically.  It is apparent that we are only now grasping how best to utilise the microgravity environment. Hence it would be a great shame if we would have to stop now when we have better understanding combined with possibilities of continuous access to the International Space station. Moreover for the British scientists, it would be a pity if others will reap the benefits of the effort that we have invested, while we will become bystanders.

 

 

 

 

 

 

 

 

 

 

 

Imperial Experiments in microgravity:

 

·        Crystallisation of Reverse transcriptase on the Russian Photon 7 ('Kashtan Mission')

·        Crystallisation of lysozyme on Spacehab 1

·        Crystallisation of crustacyanin on the IML-2 mission

·        Crystallisation of crustacyanin on the UMSL-2 mission

·        Crystallisation of crustacyanin on the LMS mission

 

PUBLICATIONS

 

·        Chayen, N.E., "Microgravity Protein Crystallisation Aboard the Photon Satellite" J. Cryst. Growth 153 (1995), 175-179.

·        Chayen, N.E., Gordon, E.J. and Zagalsky, P.F., "The Crystallisation of Apocrustacyanin C1 on the International Microgravity Laboratory (IML-2) Mission" Acta Cryst. D 52 (1996), 156-159.

·        Chayen, N.E., Snell, E.H., Helliwell, J.R. and Zagalsky, P.F., "CCD video Observation of Microgravity Crystallisation: Apocrustacyanin C1" J. Cryst.Growth 171 (1997), 219-225.

·        Snell, E.H., Cassetta, A., Helliwell, J.R., Boggon, T.J., Chayen, N.E., Weckert, E., Holzer, K., Schroer, K. Gordon, E.J. and Zagalsky, P.F., "Partial Improvement of Crystal Quality for Microgrvity Grown Apocrustacyanin C1" Acta Cryst. D  53 (1997), 231-239.

·        Ries Kautt, M., Broutin, I., Ducruix, A., Shepard, W., Kahn, R., Chayen, N., Blow, D., Paal, K., Littke, W., Lorber, B., Theobald-Dietrich, A. and Giege, R., "Crystallogenesis Studies in Microgravity with the Advanced Protein Crystallisation Facility on SpaceHab-01" J. Cryst. Growth 181 (1997), 79-96.

·        Boggon, T.J., Chayen, N.E., Snell, E.H., Dong J., Lautenschlager, P., Potthast, L., Siddons, P. Stojanoff, V., Gordon, E., Thompson, A., Zagalsky, P.F., Bi, R.C.and Helliwell, J.R., "Protein Crystal Movements and Fluid Flows During Growth" Phil. Trans. R. Soc. Lond. A. 356 (1998), 1045-1061.

·        Dong, J., Boggon, T.J., Chayen, N.E., Rafetry, J., Bi R-C and Helliwell, J.R., "Bound Solvent Structures for Microgravity, Ground Control, Gel and Microbatch Grown HEW Lysozyme Crystals at 1.8Å Resolution" Acta Cryst. D 55(1999) 745-752.

·        Snell, E.H., Chayen, N.E. and Helliwell, J.R., "Crystallisation of Biological Macromolecules in Microgravity" (1999). The Biochemist December issue 19-24.

·        Chayen, N.E. and Helliwell, J.R., "Space-grown Crystals May Prove their Worth"  Nature  398, (1999) 20.

·        Helliwell, J.R., Snell, E.H., Chayen, N.E., Judge, R.A., Boggon, T.J. and Pusey, M.L. "Fluid Physics and Macromolecular Crystal Growth in Microgravity" in "Physics of Fluids in Microgravity" Monti R. ed (2002)

·        Chayen, N.E. and Helliwell, J.R. (2002) "Protein Crystallization in Microgravity: Are We Reaping the Full Benefit of Outer Space?" New York Academy of Sciences in press.

 

What I have written above is a short summary of the situation. I can of course supply much more detail if necessary as well as references for all the statements made

 

Top

Name

Prof. WT Coakley

Affiliation

Cardiff University

Address

School of Biosciences,

Cardiff University,

Main Building,

Cardiff CF10 3TL

 

 

 

 

Telephone

02920 874287

Fax

02920 874305

E-mail

Coakley@cf.ac.uk

Brief summary of main points

Physical, chemical and biological components of research and development projects in space involve studies with fluidic systems and suspensions. The ability to manipulate the location of suspended materials, for example cells, colloidal materials and bubbles (including intrusive bubbles) can be provided by ultrasound standing wave traps. Standing waves in the MHz frequency range have been applied terrestrially as force field cell culture perfusion filters, water filters, for suspension washing and for studies of cell adhesion away from container boundaries. The technology is readily applicable in space for non-intrusive force field manipulations in suspensions.

 

 

 

Further details and background

Staff from our bio-ultrasonics laboratory have already been involved in self-funded studies of ultrasonic manipulation in two ESA microgravity parabolic flight programmes (Hawkes JJ, et al. Ultrasonic manipulation of particles in microgravity
J Phys D 31:1673-1680 (1998)). The work showed enhancement of microparticle separation in microgravity compared to the terrestrial situation. The primary effect was exerted through the acoustic streaming pathways. The ultrasound technique has been applied more recently in 1 g  situations to bring tissue cells together in suspension for the study of development of tissues away from solid surfaces. The ability to concentrate cell masses in suspensions has applications for the study of tissue development in microgravity conditions.   

 

 

 

 

 

 

 

 

 

 

 

 

Name

Charles Cockell

Affiliation

British Antarctic Survey

Address

High Cross,

Madingley Road,

Cambridge.

CB3 0ET

 

Telephone

01223 411722

Fax

01223 415769

E-mail

csco@bas.ac.uk

Brief summary of main points

 

Membership of ELIPS will ensure that British scientists can lead ESA programmes. For example, I was recently informed that after successfully leading an effort to establish a new ESA topical team – ROME (Response of Organisms to the Martian Environment), I would not be able to organise the Euro 20,000 we have been awarded. My colleagues in Germany, despite the fact that the PI is British, must now do this. At one point I was involved in a discussion initiated by ESA to merge the ROME topical team with another team being led by a non-British PI to resolve the problem of our non-membership of ELIPS. This situation is a disaster because it weakens our ability to provide leadership within ESA and may jeopardise future opportunities to lead ESA programmes.

 

Further details and background

 

 

 

 (Further submission below)

 

 

  

 

 

Name

Charles Cockell

Affiliation

British Antarctic Survey

Address

High Cross,

Madingley Road,

Cambridge.

CB3 0ET

 

Telephone

01223 411722

Fax

01223 415769

E-mail

csco@bas.ac.uk

Brief summary of main points

 

Being a member of ELIPS will allow us to play a more important role in defining the future of space station experiments. I am Principal Investigator on one of the experiments (EXPOSE) on the International Space Station to be flown in 2004 by ESA. My experiment involves studying response of photosynthetic microorganisms to the space environment. The lack of ELIPS membership comes up at our science meetings and it is only by the good faith of my fellow scientists that they turn a blind eye. But this is no way to conduct ourselves as a member of ESA. We need to be a member of ELIPS so future experiments are fully open to us and we can participate in defining space experiments.

 

Further details and background

 

 

 

 

 

 

 

 

 

 

 

 

 Top


 

Name

Prof J.L. Culhane, FRS

Affiliation

University College London/Mullard Space Science Laboratory

Address

Holmbury St Mary

Dorking

Surrey RH5 6NT

UK

Telephone

01483 274111

Fax

01483 278312

E-mail

jlc@mssl.ucl.ac.uk

Brief summary of main points

Exo-astrobiology is an important emerging and broadly-based discipline.

It crosses traditional discipline boundaries and funding agency structures.

In-situ studies of other solar system bodies will greatly advance this field in the next several decades.

This will occur independently of the outcome of debate on manned or robotic solar system exploration.

The search for earth-like planets around other stars is presently one of the main fields of Astronomy.

UK has a strong and growing base of practioners in both the in-situ and remote observation fields and, with appropriately targeted support, can play a leading role.

Further details and background

With the launch of Beagle-2, UK scientists are poised to expand the application of their skills in analysis of material from solar system bodies to the in-situ search for evidence of life on Mars. The discipline is strong in France, Germany and more recently Spain. It goes without saying that NASA is strongly promoting research activities in this field! UK groups are playing an outstanding role in ESA solar system exploration missions and can most effectively exploit the ESA Aurora programme should the latter proceed.

Almost by definition, crucial scientific advances will emerge at the boundaries of traditional disciplines. Exo-astrobiology is presenting a striking current example – traditionalists waste time in debating its name! Within the UK, the mechanisms that exist for the encouragement of interdisciplinary research at the boundaries of Research Council activities should be deployed to enable cutting edge research in this area. Within ESA, the Science and Life and Physical Science directorates should be strongly encouraged to work together in this field.

Human exploration of the solar system will be massively expensive and will require major extra-science drivers if it is to proceed. Development of Exo-astrobiology does not need to wait for the resolution of this very old debate. It should be pursued robotically in a cost-effective manner that does not require limitation to the Moon and Mars as sole targets though the latter is of course incredibly important for the subject.

Within the next two decades, Astronomers using advanced space-based interferometers, will have the capacity to resolve earth-like planets around stars. The specific remote sensing observations that will then become possible will be powerfully complemented by the in-situ solar system studies.  The search for and study of earth-like planets beyond the solar system along with Cosmology together represent the front line of current astronomical research. However the former must be pursued in a broad interdisciplinary context.

UK scientists have strong traditions of world success in Astronomy. Although necessarily of a more recent origin, a similar position has been established in the Space-based disciplines.  We are well placed to take a leading position in a field that has enormous potential for fundamental scientific advance and outstanding public outreach impact.

 

 

Name

Dr Nick Davey

Affiliation

Imperial College

Address

Division of Neuroscience & Psychological Medicine,

Imperial College Faculty of Medicine,

Charing Cross Hospital,

Fulham Palace Road,

London

W6 8RF

Telephone

020 8846 7284 / 7293

Fax

020 8846 7338

E-mail

n.davey@ic.ac.uk

Brief summary of main points

The “plastic” central nervous system is subjected to unchanging gravity throughout life. Postural control and more complex motor programmes are established against the backdrop of this unchanging force. We ask:

  1. How quickly and effectively can the plastic nervous system adapt to produce adequate control in the absence of gravity?
  2. How reliant are motor tasks (particularly postural ones) on the presence of gravity?
  3. What can we learn about the human central nervous system by conducting motor control experiments in the absence of gravity or in altered gravitational fields?
  4. What can this new insight add to our knowledge of adaptation and learning within the central nervous system, particularly during rehabilitation following trauma?

Further details and background

Human beings are born and grow up with the constant force of the earth’s gravity on their bodies. Exquisite motor programmes are established by allowing us to perform very complex motor tasks with extreme precision – for example playing the piano or balancing on a narrow beam. All these tasks whether dextrous or postural are performed taking into account the earth’s gravitational field. Many of the human body’s receptor systems (for example pressure receptors in the skin, joint receptors and muscle spindles) provide feedback about the way the body interacts within this field. If this constant field is suddenly removed or changed then the gain of these servo systems will be disrupted which will presumably affect the precision of postural or dextrous tasks. Since the nervous system has the ability to adjust or rewire its control systems according to need then we might expect re-learning to occur directed at regaining this lost control in the new gravitational conditions. If these processes do occur it is important to learn how quickly they are established and how permanent they are. This kind of research is of obvious importance if humans are going to spend long periods of time in altered gravitational fields. Equally, they will add to our knowledge of the way the central nervous system adapts to trauma (such as stroke or spinal cord injury) and the subsequent rehabilitation programmes aimed at restoring function. In particular, it will help to differentiate spinal cord reflexes involved in compensatory posture (for example when the centre of gravity is disturbed by a limb movement such as picking up a cup) from centrally programmed control mechanisms. Centrally programmed postural compensation for limb movement is likely to prove more amenable to rehabilitation, making restoration of lost function in trunk muscles more possible. This kind of work can only be conducted using microgravity resources such as parabolic flight, centrifuges or experiments in orbit.

 

Name

Howell G.M Edwards

Affiliation

Bradford University

Address

Professor of Molecular Spectroscopy

Department of Chemical and Forensic Sciences

University of Bradford

Bradford

BD7 1DP

Telephone

01274-233787

Fax

01274-235350

E-mail

h.g.m.edwards@bradford.ac.uk

Brief summary of main points

 

1. Project ENDO/ROSE ; response of organisms to a space environment,

coordinated by Dr. Gerda Horneck (DLR, Koln) . An ISS experiment scheduled

for next year (?) to assess the response of Antarctic extremophiles (in

collaboration with the BAS, Cambridge) such as endoliths and cyanobacterial

mats to a near-space situation. The extremophiles can survive in the most

hostile terrestrial environments exemplified by the Dry Valleys and Mars

Oasis and the project will test their capabilities in a "worst-case

terrestrial ozone-hole scenario".

 

2. Project FOTON /STONE : an on-going, multi-stage artificial meteorite

experiment to test  geological modification and biological

survival  incurred as a result of entry into the Earth's atmosphere by

extraterrestrial material (coordinated by Dr. Andre Brack, CNRS

Biomoleculaire et Biophysique, Orleans). We have simulated Martian rocks

and have so far tested their survival on the external mounting of a Russian

satellite as part of the series of Biopan experiments. The most recent of

these suffered a disaster just two weeks ago when the Soyuz rocket exploded

during  launch from Plesetsk, with the loss of the satellite and our specimens.

 

3. Several projects with NASA and ESA for the miniaturisation of remote

sensing Raman spectroscopic equipment for the detection of biomolecular

markers in planetary surface exploration (especially Mars). Links with NASA

Ames and several European groups are formed , including the Centro de

Astrobiologia, Madrid, and the Austrian Academy of Sciences, Graz. UK

involvement includes Beagle 2 and Vanguard.

 

Further details and background

 

 

Top

 

Name

Dr. Kevin Fong BSc MBBS MRCP

Affiliation

University College London

Address

University College London

Room 121, 1st Floor Crosspiece,

Middlesex Hospital,

Mortimer Street

W1T 3AA

Telephone

+44 7770 422 091

Fax

 

E-mail

Fong22@hotmail.com

Brief summary of main points

 

Summary:  A working strategy for UK space life science has been developed over the past 5 years.  As a result the Centre for Aviation, Space and Extreme environment medicine (CASE) has been established at University College London.  This group serves to co-ordinate a multi-centre research effort in this field and implements strategy dictated by the international and national space biomedical steering groups. 

 

A working business plan currently supports a first class programme of space life science education and a limited programme of research.  With appropriate resources this infrastructure has the potential to deliver world class undergraduate and postgraduate training opportunities as well as the ability to take advantage of commercial opportunities in the field of biotechnology.       

 

 

UK Space Life and Medical Science – A New Opportunity

The space environment provides a unique and powerful tool with which to investigate a host of biological and biomedical phenomena.  In addition the vast network of international field centres that support the space programme allows researchers to share information, generate new ideas, acquire new research skills and engage in first class collaborative research. 

 

The science in this field has matured in recent years and there is recognition amongst the academic community that this research is of excellent quality.  The huge rise in the impact scores of journals in which space life science research is published is clear evidence of this fact. 

 

In the United States the National Space Biomedical Research Institute (NSBRI), based in Houston, serves to co-ordinate the space biomedical efforts of leading US universities including Harvard, Massachusetts Institute of Technology, John Hopkins Medical School, Duke University and Baylor College of Medicine.  This programme has yielded first class primary scientific research as well as new biotechnology which, as well as being of clear benefit to terrestrial medicine, has also generated commercial opportunities. 

 

There exists at this time in the UK a working infrastructure capable of co-ordinating space life science research, developing productive international scientific collaborations and managing a comprehensive programme of education and research.  The strategy and existing programme have been guided over the past 5 years by UK academics as well as representatives from the international space community.  The result has been the creation of the Centre for Aviation, Space and Extreme environment medicine (CASE) and the identification of UK laboratories that would benefit from links with international space laboratories.  The existing infrastructure is supported through a working business plan and has the potential to deliver doctoral and postdoctoral researchers with a unique cross-disciplinary training in leading edge life science.  

 

CASE has been successful in building links with other institutions in the UK as well as with international agencies.  These include the European Space Agency, the National Aeronautics and Space Administration, the British National Space Centre, The Institute of Naval Medicine (UK, Royal Navy), QinetiQ {formerly: The Defence Evaluation Research Agency} (UK), Diving Diseases Research Centre
(UK, Plymouth), Duke University, Dept. of Anesthesiology and critical care
(USA), Freie Universitat Berlin (Germany), Imperial College London (UK), The Royal National Orthopaedic Hospital (UK), King's College London (UK) and Dundee University (UK).

 

Through these efforts a range of British researchers and laboratories involved in work relevant to the wider space programme have been identified. These groups are all keen to investigate the potential for collaborative research.

 

It is intended that CASE should serve to co-ordinate a multi-centre effort under the executive control of the UK Space Biomedical Advisory Committee that meets annually at British National Space Centre.  The CASE infrastructure has been developed over the past 5 years in an effort to create an environment capable of supporting the nascent interest in UK space life science research. 

 

Meetings with representatives from University College London (Prof. Mythen, Prof. Mobbs, Prof. Lieberman),  King's College London (Prof. Linden, Olga Rutherford) and Imperial College London (Prof. Ellaway, John Lever) to discuss the possibility of establishing a tri-centre doctoral and post-doctoral programme in integrative physiology are to be held in late November.  These meetings will be followed by further discussions with the British Consulate and the National Space Biomedical Research Institute in Houston. 

 

In summary it is possible to demonstrate that the science in the field of space life sciences is of excellent quality and that this programme is of both medical and commercial value to terrestrial communities.  With this knowledge and the emergence of a working UK infrastructure in this field it is clear that we should not abandon the wider international space programme.  Well targeted research and resources in the field of space life and medical science have the potential to yield positive benefits for UK programmes of education and research as well as UK industry. 

 

 

 

Further details and background

 

 

 

 

 

Name

Dr Peter J. Fraser

Affiliation

Aberdeen University

Address

Zoology Department

School of Biological Sciences

Aberdeen University,

Tillydrone Avenue,

Aberdeen. AB24 2TZ

Telephone

01224 272891

Fax

01224 272396

E-mail

p.fraser@abdn.ac.uk

Brief summary of main points

Microgravity and hypergravity facilities allow separation of gravity dependent mechanical processes.

Invited access to NASA facilities in USA cannot easily be taken up through lack of availability of Research Council Support

Further details and background

My recent finding that angular acceleration receptors are also hydrostatic pressure receptors in crabs and dogfish (Nature 371, 383-384 (1994); Nature 415, 495-496 (2002), has been of interest to NASA, leading to invites to CASSLs (Centre for Advanced studies in the Space Life Sciences) conferences, and an invitation to visit and speak at the NASA Ames Research Centre (2001)

http://www.mbl.edu/CASSLS/workshops.html  Following my visit, I have been invited to use Centrifuges and other facilities at NASA Ames Centre

But when I have tried to seek research Council advice or studentships, I have met with either no reply or told that my proposal was not in a supported area of research.

I have been able to carry out a microgravity experiment since 4 students were accepted on the recent ESA Parabolic Flight Campaign. We obtained clear, results, repeated each parabola. The whole process has attracted immense TV, Radio and press interest.

Supporting this sort of area of research could do more for recruitment into areas of science for which support is waning such as physics and maths as well as diverting biology students towards biophysics.

The role of microstrains  (c1-10 nm) in normal cell function is normally ignored, but may have great importance. Gravity normally imposes a gradient of strains in various ways, which may have vital long term functions.

 

 

 

Name

Professor Allen Goodship

Affiliation

 

Address

 

Royal Veterinary College and Institute of Orthopaedics Musculo-skeletal Science University College London

 

 

 

Telephone

0208 909 5747  01707 666342

Fax

01707 666346

E-mail

Goodship@rvc.ac.uk

Brief summary of main points

Osteoporosis and related fractures will impose extreme costs to the Healthcare system now and in the future with increased longevity and decreased physical activities.

A microgravity scenario that allows isolation of gravitational forces from cells, tissues and the living skeleton, this proved unique ability to focus on responses to specific biological and imposed mechanical cues to elucidate mechanisms that may provide pharmacological targets to prevent and treat these high morbidity degenerative diseases of the skeletal system.

 

 

 

Further details and background

 

We participated in the Euromir 95  mission to test hypotheses relating to the mechanical stimulation of bone mass. Disadvantages relate to low number of subjects and this can only be rectified by accumulation of data over a number of missions. Access on an ongoing basis with national and international networking would optimise the opportunities of this unique research platform.

 

Mechanically responsive systems such as the musculo-skeletal system together with age related degenerative conditions can gain some benefit from microgravity based research.

 

The cost benefits of such research in times of limited resource  are high but could be mitigated by an truly international approach.

 

We feel a UK presence is essential but the difficulties in appropriate funding  should be resolved.

 

 

 

 

 

 

 

 

 Top


 

Name

Monica M. Grady

Affiliation

Natural History Museum

Address

Dept. of Mineralogy

The Natural History Museum

Cromwell Road

London SW7 5BD

 

Telephone

0207 942 5709

Fax

0207 942 5537

E-mail

mmg@nhm.ac.uk

Brief summary of main points

(1) General point: why just ‘microgravity’ review –space is a very low pressure (vacuum), high radiation environment, conditions also useful for experiments and simulations.

 

(2) Specific point: My interest is in radiation damage to organic and inorganic materials.

 

 

Further details and background

 

Background: meteorites are pieces of material broken from asteroids that land on Earth. They are composed of rock and metal; some contain significant quantities of organic molecules (including amino and carboxylic acids). Meteorites have the potential to cause both the extinction of life (during giant impacts) and the creation of life (by seeding Earth with the organic precursors to DNA).

 

Potential projects:

 

1). The physical properties of asteroids (density, porosity, strength) can be deduced through knowledge of their mineralogy. Study of the processes by which radiation alters mineralogy is important, because asteroid surfaces have been modified by cratering and radiation damage, such that their spectral reflectance cannot always be matched to specific meteorite types. Identification of the material properties of asteroids (significant for hazard mitigation studies) would be facilitated by tracing the alteration of minerals during exposure to radiation in space.

 

2). Organic molecules are abundant in interstellar space, and their chemistry is partly controlled by radiation. The relationship between organic species within meteorites and those in interstellar space is complex, dependent upon the matrix within which the organics are supported, as well as the composition of the organics themselves. Identification of the radiation-mediated pathways through which simple interstellar molecules are converted to more complex species, in the presence of inorganic substrates is an important stage in the understanding of the origin of life.

 

 

 

 

Name

DR MIKE GROCOTT BSc MBBS MRCP FRCA

Affiliation

University College London

Address

Centre for Anaesthesia

1st Floor Crosspiece

Middlesex Hospital

Mortimer Street

London

W1T 3AA

Telephone

0207 636 8333 Ext 3172

Fax

0207 580 6423

E-mail

mike.grocott@ucl.ac.uk

Brief summary of main points

1.      Research opportunities presented by the International Space Station (ISS), in particular experiments utilising microgravity, will provide unique insights in medicine and the life sciences.  These insights and the applications that come from them will provide direct benefits in terrestrial medicine e.g. osteoporosis, cardiovascular deconditioning and autonomic failure.

2.      The Centre for Aviation Space and Extreme environment medicine (CASE) at UCL offers educational opportunities that are unique within the UK and Europe.  Both undergraduate (BSc) and postgraduate (MSc and PhD) programs are now established in Space and Extreme Environment Physiology and Medicine.  A novel taught diploma in Space medicine is under development. All these efforts rely on continued contact with the international agencies (ESA, NASA) and access to research opportunities in space are an essential component of this program.

Further details and background

 

Microgravity is associated with a number of medical problems including osteoporosis, autonomic impairment, and cardiovascular deconditioning.  The opportunities to study these processes in a controlled environment offered by the ISS are unique and well recognised internationally.  Access to these opportunities is essential if research in these areas in the UK is to remain internationally competitive.  Clear benefits are identifiable in terrestrial medicine from research conducted in microgravity.  Autonomic dysfunction, cardiovascular deconditioning and osteoporosis are all common conditions, integral to the ageing process, with major medical, social and economic impact within the UK.

 

CASE was established at UCL to provide unique education and research opportunities to UK undergraduates and graduates in the fields of Space and Extreme Environment Medicine and the Life Sciences.  An undergraduate BSc course in Space and Extreme environment physiology has been run for the last 3 years and an MSc program is currently being established.  A PhD program commenced in 2002.  As part of a community identification project CASE have identified a substantial group of biomedical science researchers within the UK who would clearly benefit from the opportunities presented by access to research facilities in microgravity that the ISS will provide.   As a specific example ongoing projects at CASE in the areas of genomics (osteoporosis) and integrative physiology (autonomic dysfunction) would directly benefit from such opportunities.

 

 

Name

Professor L. D. Hall

Affiliation

University of Cambridge

Address

Herchel Smith Laboratory for Medicinal Chemistry

Forvie Site

Robinson Way

Cambridge

CB2 2PZ

UK

Telephone

+44(0)1223 336805/336807

Fax

+44(0)1223 336748

E-mail

ldh11@hslmc.cam.ac.uk

Brief summary of main points

 

The ever-increasing needs for new methods for the delivery of pharmaceuticals for treatment of human diseases, has led to renewed interest in the synthesis from organic substances of microparticles as drug carriers.  Their formation at reduced gravity offers intriguing opportunities.

 

Further details and background

 

 

 

 

 

 

 

Top


 

Name

Dr M H Harrison

Affiliation

Technical Director, QinetiQ

Address

Cody Technology Park

Cody building

Ively Road

Farnborough

Hampshire GU14 0LX

Telephone

01252 393314

Fax

01252 394777

E-mail

mhharrison@qinetiQ.com

Brief summary of main points

·        From lectures and presentations I give to school children, undergraduates, and graduates, there is a very real interest, by some, in space biomedicine and, in particular, in the challenge of overcoming the tremendous physiological, psychological, and medical problems of manned space flight. They want to know how to get involved. My advice is to emigrate!

·        The UK is very strong in the biomedical sciences. Some of what we do is relevant to space biomedicine. However, juste retour prevents our scientists from participating in ESA space biomedicine programmes (2 years ago my organisation successfully bid into an ESA bed-rest study, but had to withdraw because we couldn’t find the ~ £26k required – which represented only a small proportion of the total cost of the programme, the remainder being funded by ESA. The research results would have been of civil and military relevance).

·        Some time ago an ESA bulletin listed European companies investing in the 70 identified areas of space technology. Only one was from the UK. Why?

·        Just a small investment in space life sciences (a few £M) would allow some participation in space biomedical research by UK scientists/companies. Any programme should be small, well focused, and use ground-based facilities whenever possible.

·        UK support for biomedical research could be focused in those areas likely to produce economic benefit through better understanding, and treatment, of disease conditions and the ageing process (e.g., muscle metabolism; osteoporosis; kidney function).

·         Microgravity research per se seems unlikely to offer value for money in the foreseeable future. Space biomedical research is more likely to, if conducted in partnership with ESA nations, or NASA.

·         The opportunity for UK scientists to become involved, even just to a very small extent, could be inspirational for some of our young aspiring scientists.

 

 

 

 

 

 

 

 

 

 

 

 

Further details and background

Space is going to be a major technology driver over the next few decades. The research emphasis is beginning to shift away from established space applications like Satellite Communications and Earth Observation - in which the UK has successfully invested - into areas like propulsion systems (where Britain once led the world) and space biomedicine. Not only are we declining to invest in either, but Government policy towards manned space flight has effectively ostracized the entire UK biomedical research community from participating in what has now become a truly international research programme.

We as a nation have few equals when it comes to the quality of our biomedical research. The weightless environment of space provides a unique opportunity to investigate changes in body structure and function very similar to those associated with some disease states, and with ageing. Britain should support biomedical research in space not because of any fanciful notions of eventually going to Mars or anywhere else, but because this research will ultimately benefit everyone. The plea from the international space community is not for Britons to go into space, but simply for British scientists to be able contribute to space biomedical research, even if that is restricted to terrestrial analogue studies. At present we cannot even do that.

Of course, humans will eventually travel to Mars and beyond. As things stand at present the UK will simply be a passive observer. Indeed, even the media seemingly encourages us British to be mere observers. In a front-page article a couple of years ago a leading British newspaper, commenting on an ESA request for volunteers to take part in a ground-based study to investigate effects of microgravity on humans, declared that no Briton would volunteer because “Britain has always opted out of manned space flight programmes”. Actually, Britons did volunteer!

Konstantin Tsiolkovsky, one of the pioneers of astronautics, famously said that “The Earth is the cradle of mankind, but one cannot remain in the cradle forever”. Unless, apparently, you happen to be British!

 

 

Name

Prof. JD Hunt FRS

Affiliation

Dept. of Materials, University of Oxford

Address

Dept of Materials

University of Oxford

Parks Rd

Oxford OX1 3PH

Telephone

01865 273712

Fax

01865 273789

E-mail

John.hunt@materials.ox.ac.uk

Brief summary of main points

I see almost no possibility of the commercial exploitation of space in the field of material science. I believe in blue skies research but the cost implication must be always considered. In my opinion there are other more productive/cost effective ways of using scarce research funding.

Space research has become a large flywheel rotating at great speed and the supporters argue that so much effort has been put in that funding must be found to keep it going. I support the view that it should be allowed to slow down.

Further details and background

 

I have been indirectly involved with space research for over 20 years. I have been on two committees vetting proposals for ESA and have been on various NASA committees. I will make two general comments about these meetings. I was never fully convinced that any of the materials science proposals was value for money but was told that did not matter: the proposals should just be put in order. The second comment is that NASA members always said they should do things because the Europeans were about to do it.  ESA said they should do them because the Americans were doing them.

More recently I have been more directly involved with an ESA MAP project CETSOL. I got into to this project from a thematic network because I felt that we could make a contribution to the theoretical analysis and experiments on the ground. As it turned out we were told that we would, would not, would, would not be supported. We eventually got no funding but were able to carry out our part of the project in full by other means.

It was clear in this project and others that the main objective was to support the large infrastructure on space research in France and Germany. I firmly support the view taken by the UK in the past to stand back and ensure value for money. There clearly are areas worthy of support, such as mapping, mineral surveying and communications, but I cannot see commercial advantage in the field of materials science. The benefit in materials science is likely to be an increased understanding of what happens. As such a realistic assessment should be made of the true cost of experiments in space as compared with support for equivalent work on the ground.

Having talked to scientists who have been involved with work in space over many years, I have found two main groups. Those who have an almost emotional motivation for work in space because it is a new frontier and those who when pressed say well it is a source of funding why shouldn’t I have part of it.

I do not accept either view as a reason for increased spending on space research.

 

 

 

Name

Dr DBR Kenning

Affiliation

Oxford University

Address

 

Department of Engineering Science

Parks Road

Oxford

OX1 3PJ

 

 

 

Telephone

01865 273033, 273000

Fax

01865 273010

E-mail

david.kenning@eng.ox.ac.uk

Brief summary of main points

There are exciting experiments to be done in microgravity in the field of multiphase flow, heat and mass transfer.

UK involvement in this field has been limited by the policy on contribution to ESA programmes and by the antagonistic attitude of some EPSRC reviewers to the utility of such work.

Involvement requires some assurance of long term support for a research group because of the ground-based activity that precedes flight opportunities and the uncertainties in timing that have so far been a part of the flight programme.

 

Further details and background

 

I have a very limited involvement with EPSRC funding in an ESA –supported project organised by University of Pisa and have been a member (now lapsed) of an ESA Topical Team on Boiling in Microgravity. I represented ESA on a NASA-ESA selection panel for microgravity proposals in May 2001. My comments are based mainly on this last experience. The highest-rated proposal was for boiling heat transfer experiments. Strong proposals often involved international teams (e.g. including Japan as well as European and US groups). There was nothing from the UK. (I would have loved to be involved!)

Proposals were mainly for fundamental studies but there is also a strong incentive to study multiphase flow for its potential applications in space facilities.

Projects are always expensive and relatively long term because of pre-flight validation. Young researchers must have some assurance of continued support if they are to commit themselves to this sort of activity.

 

 

 

 

 

 

 

 

 

 

 

Name

Peter D. Lee

Affiliation

Dept. of Materials, Imperial College

Address

Prince Consort Road

South Kensington

London SW7 2BP

 

Telephone

020 7594 6801

Fax

020 7594 6758

E-mail

p.d.lee@ic.ac.uk

Brief summary of main points

In the field of materials processing, microgravity facilities are highly beneficial for three key reasons: 1. calibrating techniques for thermophysical property measurements; 2. producing standards for many applications; 3. providing an environment for doing experiments to isolate key phenomena, and hence better understand what measurements are required.

 

 

 

 

Further details and background

 

In many areas of materials processing, fully characterised experiments are very difficult due to the confounding effect of gravity driven phenomena. This has lead to a paucity of data (and the concomitant understanding of processes where this data is required to characterise or model them) for a range of basic thermophysical properties of materials, such as the diffusivity of species in molten metals. A knowledge of these properties is required for the processes to be developed to produce many materials key to UK industry such as 3rd generation single crystal alloys. A microgravity facility would allow the experiments to be performed to understand how to isolate the gravity driven phenomena, and hence allow the development of appropriate measurement techniques. Both measurements and materials to be used as standards could be produced, allowing the bulk of characterisations to be carried out in terrestrial conditions.

 

A microgravity facility would therefore both speed the entry of new materials into UK industry, and provide key data required for the modelling of the processing of existing materials and the development of new materials.

 

 

 

 

 

 

 

Top

Name

DR DENNY LEVETT MA BM BCh MRCP

 

Affiliation

University College London

 

Address

Centre for anaesthesia

1st Floor Crosspiece

Middlesex Hospital

Mortimer Street

London

W1T 3AA

 

Telephone

0207 387 9300 Ext 3172

 

Fax

0207 580 6423

 

E-mail

Dennylevett@hotmail.com

 

Brief summary of main points

 

  1. Microgravity research in life and physical sciences has multiple potential  applications which would benefit both terrestrial mainstream medicine and technology.
  2. The Centre for Aviation Space and Extreme environment medicine (CASE) at UCL has already identified potential research collaborations with NASA and ESA in the fields of cardiovascular, neurological and bone physiology which could have widereaching effects on the treatment of osteoporosis, the monitoring of raised intracranial pressure post head injury, the processes involved cardiovascular deconditioning in heart failure and post myocardial infarction and dysautonomia.  These conditions cause signficicant morbity and mortality in the UK.

 

Further details and background

 

Over the past 3 years the centre for aviation space and extreme environment medicine (CASE), based at UCL has explored the potential for high quality basic biomedical science research in the field of microgravity and other extreme environments.    The centre was established to build links to develop collaborative research in these fields and provide an educational programme to develop scientific expertise.

 

Microgravity research would have numerous benefits for the UK population, both by developing basic science expertise and by providing terrestrial applications for both medical and technological problems.  The study of disuse osteoporosis in astronauts has the potential to expand our understanding of osteoporosis which causes significant morbidity and mortality in the UK.   A collaborative research project with ESA is currently in the planning stage to investigate the underlying genetic polymorphisms that may predispose an individual to the development of osteoporosis.   Likewise a planned investigation of cardiovascular deconditioning in microgravity may provide important benefits in the fields of rehabilitation post myocardial infarction and in the treatment of heart failure, again prevalent conditions in the UK.

There are several historical examples of technologies developed for use in space flight benefiting mainstream medicine – light emitting diodes used initially in shuttle plant growth experiments have had unpredictable applications in the development of photodynamic therapy for refractory tumours;  stereophotogrammetry, developed to study the effects of microgravity on the spinal column, is now used to monitor the progression of scoliosis in children without exposing them to the damaging effects of ionising radiation.  Collaboration between UK and NASA researchers has led to the development of a technique for the non-invasive measurement of intracranial pressure which may have widespread applications in the management of head injuries, intracranial shunts and intracranial tumours.

 

As CASE has identified, a community of biomedical science researchers exists both in the UK and abroad which would benefit from the provision of microgravity research facilities.  As illustrated such research could have far-reaching benefits for UK citizens.

Top

 

Name

Nicholas Lockerbie

Affiliation

University of Strathclyde

Address

Department of Physics,

107 Rottenrow,

Glasgow G4 0NG,

Scotland,

UK

 

Telephone

(+44) (0)141 5483360/3478

Fax

(+44) (0)141 552 2891

E-mail

N.Lockerbie@phys.strath.ac.uk (work)  Nlockerbie@AOL.com  (home)

Brief summary of main points

I believe a UK microgravity programme of research would reap the following benefits for the physical sciences: -

 

A microgravity environment aboard the ISS would make possible many experiments in the hugely important and topical area of Fundamental Physics that are impossible, or at best severely circumscribed, on the ground.  Examples are: tests of the Equivalence Principle (EP) for inertial and gravitational mass, long-term tests of General Relativity (using atomic clocks and/or Pulsar references), accurate measurement of the Gravitational Constant, testing the Inverse-square Law of gravity at short-range, the Casimir Effect, precision Atomic Interferometry, Dark Energy/new interaction searches, etc.

 

Secondly, a suitable microgravity environment could also be used for appropriate technology development in support of e.g. space borne long-baseline gravity wave detectors (development and testing of micro-thrusters, such as FEEPs, ‘drag-free’ sensing and control of test masses hardware/software, long-term laser optical bench testing, etc.).  Equally, it could be used for gravitational quadrupole testing (a particular interest of my own, with application to EP tests), which is limited by bearing-friction under 1g on the ground, and would be enormously enhanced in sensitivity (by a very useful factor of > 103) by operation under micro-g accelerations.

 

And thirdly, a low-Earth-orbit laboratory could be used for medium baseline (several metres) Gravity Gradiometry, using ‘string-sensor’ gravity gradiometers—with a potential sensitivity of 10-4 Eötvös/√Hz, or better.  Such an instrument would borrow heavily on optical techniques developed for ground-based gravity-wave detectors.  It might find application in space borne geophysical searches for minerals (oil/gas, gold, etc.), as well as, it must be admitted, having some foreseeable military uses.

 

Further details and background

I am a member of the European Topical Team, funded by the European Space Agency, with a remit to investigate the potential of the ISS for scientific experimentation in a micro-gravity environment.

I am also an ad hoc member of PPARC panels reviewing UK gravity wave work, and SMART2.

My current research into ‘string gradiometers’ is funded by Gravitec Ltd.

 

 

 

Name

Roger Longstaff

Affiliation

Guest Associates (Europe) Ltd.

Address

6 Great Owl Road
Chigwell
Essex  IG7 6AL

Telephone

020 8500 8607

Fax

020 8500 8607

E-mail

roger9996@aol.com

Brief summary of main points

1. UK Space Policy

UK Space Policy has evolved over the last two decades in a piecemeal manner. In the mid 1980s the UK was selected to lead on the Polar Platform element of the Columbus Space Station programme, starting the national focus on Earth Observation that continues to the present day. Despite continuing efforts to fund commercial development in this area, however, little competitive advantage has been gained for the UK, as UK industry has now lost the ability to design and build full size satellites and future business in this area seems likely to be dominated by those who control the space assets, and consequently their data streams. Similar arguments may be applied to both communications and navigation satellite systems. (It may be remembered that in the 1980s HMG forced a UK-only industry bid for the SKYNET 4 satellite system - this could no longer happen in the 21st Century).

Also in the 1980s, a critical decision was taken in 1987 that the
UK would not participate in the ESA space plane programme called HERMES. This decision, in itself, was correct - the programme was not viable and was subsequently cancelled. However, the decision also excluded the UK from the Ariane 5 development programme and also applied to all manned spaceflight activities in ESA. Consequently, the UK (alone among the G8) played no part in the design, construction and operation of the International Space Station (ISS), and UK researchers must now pay a heavy premium to access ISS facilities. Thus, by doing nothing, HMG policy has relegated UK academia and industry to a non-competitive status in this area.

With hindsight it seems that all of the decisions taken at the time were wrong, but for all of the right reasons. The lack of a "joined up" approach has left sections of
UK industry (e.g. the aeronautics industry, the pharmaceutical industry, etc.) at a competitive disadvantage. This should not be taken as solely a criticism of HMG policy makers - industry clearly has failed to "get its act together" and work in partnership with government. As an example, the only representation on the subject of microgravity R&D made to the Trade and Industry Select Committee in 2000 was my own (see T&I Select Committee Report on UK Space Policy, July 2000).

 

Further details and background

2. Background of Microgravity Consideration in the UK

There have been endless academic reviews of this subject over the last two decades. Few reports have been published and there has been a negligible effect on
UK policy. The current review is thus highly unlikely to influence future policy.

In 1996 my company was retained by BNSC/DTI to investigate the potential application of microgravity R&D in the
UK pharmaceutical industry. A report was produced (DTI ref. SPT/2/3/6) that highlighted the views of leading industrialists (and academics) and strongly recommended that UK researchers be granted access to orbital laboratory facilities. My company subsequently assisted Glaxo Wellcome to apply for research facilities on board a space shuttle flight. My recommendation in the report, and in writing on many subsequent occasions, was that a programme of carefully selected experiments, formulated with both industrial and academic participation, be conducted in order to evaluate the technology and assist future policy formulation. Unfortunately, this never happened, and the UK currently finds itself virtually excluded from this technology. It is interesting to reflect that the single most promising area of research, according to industry, was determined to be protein crystal growth, applied to structure based drug design. US industry currently has several drugs that were developed from space-based data undergoing clinical trials. However the UK website (www.microgravity.org.uk) makes no mention of this technology at all! (It is also discouraging that the sections "how do I access facilities", and "how do I get involved" are "not available").

Suggestions by my company to both the Minister and DG/BNSC to progress this area by organising selected industrial experiments have been politely declined over the years, with the reason given that academics, research councils, etc. were reviewing the subject, and that I would be kept fully informed. However, no reports have been published and one review has merged into another while other nations have pressed ahead and the
UK has remained isolated.

I believe that this situation (as identified by the Select Committee) has arisen as a consequence of the structure and financing of BNSC. The science budget has always been dominated by PPARC, which has had no desire to see the
UK’s mandatory contribution to ESA diverted away from space astronomy projects. This situation, coupled with the UK’s refusal to contribute to ESA’s (optional) Manned Spaceflight and Microgravity programme, has ensured that negligible funding has been available to initiate R&D activities, despite the stated intention of industry to co-fund space-based experiments.

3. The Way Ahead for the UK

There are two possibilities - either the UK has "got it right", and everybody else is wasting vast amounts of money on orbital laboratory facilities, or alternatively, that HMG policy has placed some of our high technology industries at a competitive disadvantage. As the
UK can no longer compete in the areas of traditional manufacturing and heavy engineering, the future of the profitability and employment prospects of UK industry relies almost exclusively on high technology processes and products. To deny a whole area of future technology to industry is, in my opinion, highly dangerous and not in the public good.

It would be counter-productive to complain of past mistakes and lost opportunities without suggesting a way ahead. There is, in my opinion, only one way to move the situation forward.
UK industry, supported by academia, must be allowed to conduct selected flight experiments - with a commercial rationale - and HMG must support this activity via international treaties. An Announcement of Opportunity should be issued by the DTI and experiments selected by a small panel of specialists from industry, academia and government. This would have the effect of focussing the minds of interesting parties, and evaluating the willingness of industry to commit R&D funding to the process (i.e. ground-based preparation activities and post-flight analysis). HMG, in this process, would be required to negotiate flight opportunities with potential providers (e.g. ESA, NASA or Russia).

I believe that this is the only sensible way forward. I have my own views about the most likely candidates to benefit from microgravity R&D, and doubtless academic reviews will produce others. However,
UK industry has already request space flight evaluation, and in my opinion it must be progressed now!

 

 

 

 

 

 

 

 

 

 

 

 

 

Name

Prof. Matthew J. Dring & Dr. Thomas Wiedemann

Affiliation

Queen’s University Belfast

Address

Marine Laboratory

12 The Strand

Portaferry

BT22 1PF

 

Telephone

028 427 27803 or 028 427 27808

Fax

028 427 28902

E-mail

m.dring@qub.ac.uk or t.wiedemann@qub.ac.uk

Brief summary of main points

·        Microgravity research for medical applications in conjunction with marine biology

·        Interdisciplinary approach of research is fundamental for end user products

  • Micro gravity can reveal many secrets of marine life, important or potentially important to new applications on earth

Further details and background

One of the potentially benefiting projects from a UK microgravity programme with every single person in the UK and abroad as potential beneficiary.

Proposal Title of intended project: Influence of bone growth factors and bone inductive material (Hydroxyapatite) derived from the marine alga Corallina officinalis on the performance of bone cells under changed gravity conditions.

ABSTRACT:

The suitability of an apatite from a calcareous red alga as a substance that promoted the re-growth of human bone was first reported in the late 1980s. This apatite material showed a high interconnecting pore structure (up to 50 m2/g) and, therefore, served as an osteoconductive structure.  The source for this hydroxyapatite is a marine calcareous red alga, Corallina officinalis. 

We intend to investigate the structure of the calcareous skeleton of the marine red alga Corallina officinalis, which forms the source for the hydroxyapatite (HA) under micro gravity conditions and the performance of bone cells under stem cell- and growth factor enriched conditions under these conditions.

The objectives of the project are to investigate the effect of gravity on the structure of the calcified algal skeleton and to gain further knowledge on the effect of micro gravity on growth stimulated bone cells in vitro, enclosed in “scaffolding” polymer matrix.

The potential benefit from micro gravity research may be in an enforced growth of the plant and a thinned cortex layer, which is at the moment limiting the use of the plant to large segments only in order to break them into small, large surface fragments. Furthermore the use of stem cells and other bone growth enhancing factors within the experiments might lead to preflight treatment to prevent or at least slow down the osteoporosis effect of humans in space and create new insight into possible treatment for patients on earth.

The planned project complies with the topics of the ESA program of Biology Biotechnology Biomedicine Biophysics.

 

 


 Top

Name

Dr Patrick Magee

Affiliation

University of Bath

Address

Department of Anaesthesia

Royal United Hospital

Bath BA2 7AT

 

Telephone

01225 825057

Fax

01225 825061

E-mail

Ptmagee00@aol.com

Brief summary of main points

        My interest is in the delivery of high dependency medical care in a microgravity environment. Sooner or later there will be a need to do so before transporting a critically ill or injured crewmember back to Earth after a delay of up to 90 days. Experience hitherto has shown that such procedures can be difficult in microgravity, especially in the hands of crew inexperienced in health care. There is therefore a need to develop training and technology to improve this, and there is an opportunity here for UK involvement in the development of such protocols and devices.

 

 

Further details and background

          Intensive care of a patient who is critically ill or injured frequently starts with the care pathway of ‘A,B,C’ for Airway, Breathing, Circulation. This means  securing the patient’s airway with an endotracheal tube or laryngeal mask, carrying out artificial ventilation manually or with a ventilator, inserting peripheral intravenous, central venous and arterial cannulae to secure the heart and circulation, and then giving medications to improve the patient’s condition. These are processes involving manual dexterity as well as medical knowledge, and are challenging enough when carried out by skilled and experienced staff in a terrestrial, 1G hospital intensive care environment, with all the backup possible. They are likely to be difficult in a microgravity environment, when carried out by crewmembers inexperienced in medical care, and the conditions are otherwise far from ideal for delivery of intensive care.

            Therefore, the availability of microgravity resources in the UK would allow the development of a training environment for medic-astronauts to carry out these procedures. If the resource is to be the provision of parabolic flights, the time available on each loop would be limited, but would nevertheless be valuable. Such a provision would also allow knowledge to be gained in other invasive medical procedures in a microgravity environment, such as endoscopic surgery, epidural analgesia and other anaesthetic techniques.

            It would also allow medical engineering experts to deduce ways and develop hardware to aid, for example, securing the patient, intubating the airway, securing intravenous, central venous and intra-arterial lines, and other invasive medical procedures.

            The development of such techniques and devices would have terrestrial spin-off value, and would provide an opportunity for UK manufacturers of medical equipment to be at a cutting edge of medical technology.

 

 

 

 

Name

M. A. Mendes-Tatsis

Affiliation

Imperial College

Address

Department of Chemical Engineering and Chemical Technology

Imperial College,

London SW7 2AZ

 

 

 

Telephone

020 7594 5584

Fax

020 7594 5604

E-mail

a.mendestatsis@ic.ac.uk

Brief summary of main points

·        I have carried out research which benefited from the microgravity environment provided by the ESA parabolic flights – I participated in three of ESA’s parabolic flight campaigns (i.e. 9 parabolic flights)

 

·        I am a member of an ESA international (Belgium, France and Spain) topical team working on “Environment and Biological Life Support Systems”, for the ISS.

 

·        Since I started my involvement with ESA, in 1988, I have always had comments from colleagues in Europe about the negativity of the UK towards microgravity research – this is not needed when it is already difficult enough to do the work. I have also noted, a lack of infrastructure to enable researchers easier access to microgravity research facilities. All the work I have carried out has been out of my own pro-activity and my seeking for help within ESA. 

 

·        A lot of research is being carried out in the field in Europe. The UK researchers will miss vast opportunities in the future to the detriment of the UK competitiveness in the field (which is nearly non-existent at the moment when compared to other countries) if the UK does not set up an active, well publicised programme, which will enable researchers to carry out microgravity research and take advantage of the ISS facilities. 

 

·        Therefore, I very much support the setting up in the UK of a programme of research in life and physical sciences using microgravity, which could create infrastructures, publicise opportunities and provide financial support for microgravity research.

 

Further details and background

 

 

 

 

 

 

 

 

Name

Hugh Montgomery

Affiliation

UCL, Cardiovascular Genetics

Address

3rd Floor

Rayne Institute

5, University Street

London WC1E 6JJ

Telephone

0207 679 6965

Fax

0207 679 6212

E-mail

h.montgomery@ucl.ac.uk

Brief summary of main points

 

  1. I believe that there IS potential value of such involvement to the UK.
  2. Much of the direction which might offer best value has, to my mind, been mis-stated.

 

Below are some thoughts as to valid strategy

 

Further details and background

 

It seems to me unlikely that large-scale investment in biomedical experimentation in space itself will offer good ‘value for money’. Much such work will be speculative and using small numbers, where style and presentation may triumph over content.

 

I would advocate concentrating collaborative research- with co-funding from the US/ European programmes- on areas which have direct application to earth-bound physiology and pathophysiology and which have similar direct relevance to the microgravity environment.

 

Such areas might most obviously be thought of as:

  1. Regulation of musculoskeletal form and function
  2. Responses to prolongued hypoxia (as is planned for long-duration space flights such as the Mars mission)

 

Both of these areas have the following advantages:

  1. The results are of importance to spaceflight, and funding will thus be available from USA/ ESA.
  2. The issues are possible to address using conventional physiological strategies
  3. Such experiments may be performed on Earth, and do not need the huge ‘add-on’ costs of the space environment.

These studies have been- to now- limited by finance and logistics. Thus, it has taken a NASA/ ESA initiative to instigate the bed-rest study. Financial involvement in this would have allowed expansion- such that larger numbers of subjects could be involved, and more detailed phenotyping possible. It would also have lubricated UK access to results and expertise.  Findings are relevant to space, but also to investigation of osteoporosis, disuse atrophy, critical illness/ chronic illness bedrest and so forth, thus finding direct correlates on Earth.

Similar benefits accrue from studies relating to chronic exposure to hypoxia- at present, hard to fund on a large scale, and with obvious clinical relevance.

 

 

  

Name

Professor Marco Narici

Affiliation

Manchester Metropolitan University

Address

Centre for Biophysical and Clinical Research into Human Movement

Hassall Road, Alsager ST7 2HL Cheshire

 

 

 

 

Telephone

0161-247 5659

Fax

0161-247 6375

E-mail

m.narici@mmu.ac.uk

Brief summary of main points

The study of actual or simulated microgravity opens an invaluable window on the understanding of the fundamental mechanisms underlying physiological and pathological phenomena leading to muscle wasting and loss of mobility in health and disease. Major applications of the knowledge derived from microgravity-based experiments are found in the study of ageing, stroke, and inactivity. The knowledge of the fundamental mechanisms responsible for muscle wasting in these conditions proves extremely useful for the implementation of effective countermeasures.

Further details and background

Ageing, stroke and microgravity all lead to muscle wasting, often resulting in a detrimental loss of mobility. Microgravity, be it actual or simulated, offers the possibility of studying the phenomenon of muscle atrophy mainly due to disuse as well as its functional consequences. Such knowledge proves fundamental for the study of common conditions such as ageing and stroke. As a matter of fact, the muscle wasting commonly found in ageing is due to ageing per se as well as to the effect of disuse. Hence, knowledge of the changes due to disuse will help to differentiate and understand the musculoskeletal changes due to the pure phenomenon of ageing.

Similarly, in other debilitating conditions such as stroke, disuse commonly leads to severe muscle wasting and corroborates to the loss of mobility induced by this condition as well as interfering with the process of rehabilitation. At present, very little is known on the type of muscle wasting and functional alterations observed in stroke. Hence, information on the molecular, biochemical, structural and functional alterations of skeletal muscle induced by this condition will be extremely useful for the development of targeted rehabilitation programmes.

Both the European Space Agency and NASA have excellent facilities to simulate microgravity in highly controlled conditions. The use of these facilities will enable investigators to study the fundamental mechanisms responsible for disuse muscle atrophy therefore enhancing the present understanding of the causes of muscle wasting in old age and in pathological conditions, such as stroke.

 

 

 

 

 

 

 

 

Name

Terence Partridge

Affiliation

MRC

Address

Muscle Cell Biology Group,

MRC Clinical Sciences Centre,

Hammersmith Hospital,

Du Cane Road,

London W12 0NN

 

Telephone

020 8383 8263

Fax

020 8383 8264

E-mail

terence.partridge@csc.mrc.ac.uk

Brief summary of main points

Access to microgravity environments for biological experiments could have advantages in two fields of medical interest.  One is clearly of restricted interest, namely, the impact of long-term space flight on future astronauts. The second is the possibility of dissecting the components of complex situations in which gravitational unloading may influence biological parameters via a number of different pathways: for example the direct effects of physical stress and the indirect effects unloading the cardiovascular system on calcium homeostasis in bone.

 

Further details and background

For most of the medically important conditions of which I am aware that arise from changes in rerespect of interaction with gravity, e.g. muscle atrophy or osteoporosis due to bedrest , access to microgravity environments would be of little if any benefit. 

Perhaps there are tissue culture situations or physical  systems such as micro-encapsulation which might be set up in a unique way in microgravity environments. However, these would need to be very important and justified by detail argument to merit the expenditure involved.

 

 

 

 

 

 

 

 

Name

Peter Quested/Ken Mills (ex NPL and now visiting Professor at Imperial College.)

Affiliation

Materials Centre; National Physical Laboratory;           

Address

Teddington

Middlesex

TW11 0LW

 

Telephone

020 8943 6141

Fax

020 8943 6141

E-mail

Peter.quested@npl.co.uk; mmtm@tesco.net

Brief summary of main points

For properties of high temperature liquids, density driven convection can affect the measurement. Two examples of important properties needed industrially where this affects the measured values are thermal conductivity and diffusion coefficients used in various process models.  There would be significant advantages in making these measurements under micro gravity conditions to suppress the density driven convection effects.

Any microgravity experiments should be backed by an integrated terrestrial measurement programme to exploit the microgravity results.

 

 

Further details and background

Ken and I are both interested in the measurement of thermophysical properties at high temperatures relevant to industrial processing of metals and some other materials. . There are some advantages of microgravity experiments for liquids. In low gravity environments density driven convection is suppressed, the inherent thermal conductivity of low viscosity materials is measured without inducing the complications of convection. This is also important in the measurement of diffusion coefficients in the liquid which are becoming relevant in some microstructural models of defects in castings which are important in aero and stationary gas turbines castings.

 

Experiments such as these could provide useful reference materials and also better knowledge about corrections of terrestrial measurements .

 

There are some advantages in levitation experiments in microgravity for measuring liquid properties since the forces required to overcome gravity are not required and frequently the measurement is simplified. Egry’s work on surface tension measurement is an important example.

 

We are of the opinion though that any programme using microgravity is linked with a strong terrestrial measurement programme so the knowledge gained from microgravity can be applied to terrestrial measurements.

 

 

 

 

 

 

Name

Dr Jonathan Reeve

Affiliation

MRC External Staff and Consultant Physician

Address

University Dept Medicine Box 157

Addenbrooke’s Hospital,

Cambridge

CB2 2QQ

 

Telephone

01223 741617

Fax

01223 741618

E-mail

michele@srl.cam.ac.uk

Brief summary of main points

 

Microgravity is extremely pertinent to osteoporosis, with the inactive elderly losing bone strength rapidly in a pattern similar to that seen in astronauts. Scientifically, space offers rare opportunities for experimental as distinct from merely observational studies on the causes of and mechanisms underlying osteoporosis. With the possibility of ethical human experimentation, despite a relative dearth of good animal models, progress could be substantially enhanced in this important area (hip and other osteoporotic fractures cost the exchequer about £1.8 billion a year).

The add-on costs of bone research based on space flight would be considerable and would probably have to form part of an integrated package with other human systems research to be anywhere near cost effective within the context of current MRC norms.

 

 

Further details and background

 

See my presentation from August 5th.

For some background to the osteoporosis problem see the following websites:

http://www.srl.cam.ac.uk/epos/epospublications.html

http://www.srl.cam.ac.uk/epos/DoM_pubs.html

http://www.nos.org.uk/

http://faculty.washington.edu/smott/

 

 

 

 

Name

Professor Michael J Rennie PhD FRSE

Affiliation

Symers Professor of Physiology University of Dundee

Address

Division of Molecular Physiology

University of Dundee

Dundee DD1 4HN

Scotland

Telephone

01382 344572

Fax

01382 345514

E-mail

m.j.rennie@dundee.ac.uk

Brief summary of main points

1) Microgravity in space and many earth bound conditions lead to same final common pathway i.e.  sarcopenia and osteopenia.

2) Earth bound studies will have payoffs (including better countermeasures) for astronauts and  the elderly and those with chronic disease

3) The pace, scope and quality of current physiological and pathophysiological work would improve by the contributions of UK workers.

4) We need earmarked life science space research resources to fund valuable work which currently falls between many stools.

Further details and background

           I will only refer to my own particular interests for the sake of brevity.

           Microgravity during spaceflight causes wasting of muscle (sarcopenia) and bone (osteopenia).  Sarcopenia and osteopenia are major co morbidities in many chronic diseases such as diabetes, cardiovascular disease and cancer and of course osteoporosis. They also diminish the quality of life during ageing and increase risks of falling and fracture. The ESA sponsored short and long terms bed rest studies would provide an ideal platform to study the effects of physical inactivity on muscle and bone metabolism in a way that cannot be accomplished otherwise.

           Possible payoffs would be applicable on earth AND in space especially in terms of discovering and developing countermeasures.  

           Some UK scientists have techniques (e.g. for measurement of connective tissue (including bone) metabolism), which are not available elsewhere in Europe or the USA.

Collaboration with ESA and NASA would benefit us and them (a) by increasing the power and scope of ground based studies (b) by providing them with access to techniques they do not possess (e.g. novel 18O2 gas-based method for assessing bone collagen turnover in space, or 13C- gut motility and hepatic metabolism techniques) for application in space. 

            I had a recent project approved by ESA and alpha rated by the MRC after peer review but not funded - because it was not a strategic priority for the MRC despite the fact that it would have been of relevance to intensive care medicine which is an MRC strategic priority!  Earmarked ring fenced life sciences space research resources could have saved this project.

            If access can be made available to the ISS, there is a host of both human studies and cell biological studies that could be carried out with benefit to basic biological understanding and for applied research.

            Other promising areas of research which deserve more study in space include cardiovascular, neurophysiological, and properties of the human body in space. 

 

 

 

Name

TJ Stevenson

Affiliation

University of Leicester

Address

 

Space Research Centre

University Road

Leicester

LE1 7RH

Telephone

0116 252 3504

Fax

 

E-mail

Tst@star.le.ac.uk

Brief summary of main points

High stability time measurement –performance limitation removed in microgravity conditions

 

 

Further details and background

 

There are already a number of proposals to used the Space Station as a timekeeping platform, and ESA will fly the Atomic Clock Ensemble in Space (ACES).

 

UK involvement in this programme is minimal, but the interest is high bearing in mind the applications of high precision timebases (Global Positioning, interferometry, etc) some of which have UK strategic significance.

 

 

 

 

 

 

 

 

 

 

 

 

Name

Dr J R R Stott

Affiliation

Principal Medical Officer, Centre for Human Sciences

Address

QinetiQ Ltd.

Cody Technology Park

Building A 50

Ively Road, Farnborough

Hampshire, GU14 0LX

Telephone

01252 394406 / 394891

Fax

01252 392097

E-mail

jrstott@qinetiq.com

Brief summary of main points

Space sickness reduces the well-being and effectiveness of 50% of astronauts in the first 2 – 4 days of a mission.

Space sickness is a form of motion sickness.

What we call motion sickness is an emetic mechanism that has not evolved just to make humans sick on fairground rides and ferries.

There is evidence that this mechanism is involved in vomiting from opiates, vestibular disorders and following strabismus surgery.

Efforts to solve the problem of space sickness will be of direct benefit in improved treatment for emesis in a variety of clinical conditions.

 

 

Further details and background

Motion sickness is a source of misery to those who suffer and mystified amusement to those who think they don’t. Expressed in the form of space sickness it has been shown to affect over 50% of astronauts for the first 2 – 4 days of a mission (and occasionally longer). This problem has provoked research into the possibility of its elimination through selection procedures and pre-conditioning. There has been much pharmaceutical research involved in the development of 5HT3 antagonists for the treatment of chemotherapy and radiation-induced vomiting, but this group of drugs has been shown to be ineffective in motion-induced vomiting. No new drugs that are of value in motion-induced vomiting have emerged since the chance discovery of the prophylactic benefit of centrally acting anti-histamines such as cyclizine and promethazine. All these drugs tend to impair performance on account of drowsiness.

The use of the term ‘motion sickness’ tends to obscure the fact that this emetic mechanism has evolved as a means of eliminating ingested toxins. Whereas the 5HT3–based mechanism acts at the level of the gut, the motion sickness mechanism is based within the CNS and detects toxins that disturb the integration of vestibular and visual signals generated by motion. The observation made over 40 years ago that healthy volunteers given intramuscular opiates only developed nausea and vomiting if they were allowed to move about suggests that vomiting from opiates occurs through the motion sickness mechanism.

If the problem of space sickness were to trigger further pharmaceutical research into its solution, it would be of benefit to a far wider group of individuals who suffer vomiting from a variety of clinical conditions, as well as to the motion sickness-susceptible travelling public. 

 

 

 

Name

Professor Ian A. Sutherland

Affiliation

Brunel Institute for Bioengineering

Address

Brunel University

Uxbridge

UB8 3PH

 

 

Telephone

01895-271206

Fax

01895-274608

E-mail

ian.sutherland@brunel.ac.uk

Brief summary of main points

Brunel Institute for Bioengineering (BIB) pioneered Space Glovebox technology in the late 1980’s and early 1990’s.  As Britain did not contribute to the ESA’s manned space flight programme the technology had to be transferred to a Dutch company Bradford Engineering.  While the development was collaborative to begin with, BIB eventually had to put up with sub-contract status for industrial return reasons.  The outcome has been the development of one of NASA’s most utilised space facilities with the credit and recognition going to Bradford Engineering and The Netherlands.  Bradford Engineering, now the technology has been successfully transferred, no longer need our expertise.  They now have developed a successful business based on this technology, which has spun out to other “clean air” type programmes.

 

 

Further details and background

 

The unique environment of microgravity and the lack of convection have inspired the development of space gloveboxes based on a closed loop air circulation and filtration systems.  In unit gravity, glovebox technology is still open loop, as the regulations governing pollution of our environment have not yet got to the stage where it is economical to close the loop.  However, this situation may well change and a technology which was developed for the relatively limited application of a few spacecraft could find an application in all scientific laboratories.  It could also find application in aircraft where closed loop air circulation without filtration can greatly aid cross-fertilisation of infections.

 

Another example of space technology developed as part of the space programme by BIB, which has spun out to the benefit of the community is shape memory alloys (SMA).  In 1994 Anson Medical Ltd was spun out from the Institute on the basis of the medical applications of its SMA space technology.  The company now make implanted devices such as SMA stents for the treatment of cardiovascular disease (aneurysms, occlusive disease and other vascular dysfunction).  On flotation and acquisition the value of the company was £16.2m.

 

 

 

 

 

 

 


Top 

Name

Professor Pankaj Vadgama

Affiliation

Director of the IRC in Biomedical Materials

Address

Queen Mary, University of London

Mile End Road

London

E1 4NS

 

Telephone

020 7882 5285

Fax

020 8983 1799

E-mail

p.vadgama@qmul.ac.uk

Brief summary of main points

There was an MRC Consultation meeting held recently, and I was asked to provide a view point. My personal view remains that there is very limited, in depth know-how that would accumulate in relation to the costs incurred on undertaking biomedical sciences research. The fundamental question for medicine is the usefulness of microgravity as a model to study chronic/long-term medical conditions. There would be value in studying acute phenomena, e.g. haemodynamic effects, but there would not be an opportunity to use earth-based, sophisticated monitoring systems. They have been associated with a biochemistry analysis module for the space station, and this poses interesting technical challenges. Arguably, some methodological benefits could arise from the challenge of analysis under microgravity, but I would question the earth-based value of this.

 

Further details and background

 

Notwithstanding the above, there may be some benefits to looking at short term dynamic effects at cells and proteins. Short term experiments where surface and chemistry induced cell orientation is monitored with and without microgravity might give insights into surface cues or chemical cues, working with and against gravitational traction forces. There would be some value to looking at metabolic profiles and hormonal cycles in vivo biochemically. My problem would be that whilst observations were made, our mechanistic understanding would not necessary be increased. The challenge ultimately for those driving towards microgravity research is to stipulate what the hypotheses are, and then to determine the quality of these hypotheses.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Name

Dr T L Whateley

Affiliation

University of Strathclyde

Address

Department of Pharmaceutical Sciences

27 Taylor St.

Glasgow, G4 0NR

Telephone

0141 548 2137

Fax

0141 552 6443

E-mail

t.l.whateley@strath.ac.uk

Brief summary of main points

As the only UK Leader of a ESA Topical Team, I feel that it is essential that UK contributes to ESA ELIPS (European Programme for Life and Physical Sciences and applications utilising the International Space Station) , so that UK scientists can have access to ISS and ESA support for our project, which falls into two of the highlighted ELIPS areas of interest i.e.Improving Health; and Innovating Technologies and Processes

Further details and background

Our ESA Topical Team has been funded for a period of 3 years and the next stage to utilise the ISS will require a Microgravity Applications Program: unless UK contributes to ELIPS, I (as Team Leader) and other UK members of the team will not be able to participate.

The project on Microencapsulation in Microgravity has been favourably assessed by ESA as a valuable interdisciplinary project, involving both the life and physical sciences. The fundamental science relates to the interfacial fluid physics of interfacial mass transport and interfacial turbulence and pattern formation resulting from Marangoni effects. This is important in emulsion science and technology and in the microencapsulation of drugs to manufacture sustained release drug delivery systems  At present, these microsphere based products are imported from Japan and USA and methods for European industry require to be developed. A simple method of production, possible in microgravity, could produce a pharmaceutical product valued at ca.5,000,000 Euro from one kilogram of material: such a high value/low mass product is feasible for production on ISS.

 

 

 

 Top